NeueHealth, Inc. (NYSE: NEUE) Stock Competitors & Peer Comparison
See NEUE's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Equipment & Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NEUE and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NEUE | $6.75 | +0.00% | 60.9M | -0.38 | -$17.65 | N/A |
| SIRO | $109.97 | +0.00% | 22B | 31.88 | $3.45 | N/A |
| HIMS | $31.59 | +6.51% | 7B | -315.90 | -$0.10 | N/A |
| MMED | $19.60 | +6.41% | 5.5B | -25.29 | -$0.78 | N/A |
| OMCL | $36.81 | +1.80% | 1.7B | 19.27 | $1.91 | N/A |
| DRTS | $13.14 | +1.15% | 1.2B | -19.61 | -$0.67 | N/A |
| MLAB | $102.65 | +1.62% | 574.4M | 10.36 | $9.91 | +0.62% |
| LAB | $0.80 | -0.01% | 313.2M | -11.43 | -$0.07 | N/A |
| STXS | $1.42 | +4.41% | 139M | -8.35 | -$0.17 | N/A |
| FONR | $19.09 | +0.00% | 117.8M | 19.09 | $1.00 | N/A |
Stock Comparison
Sirona Dental Systems, Inc. (NASDAQ: SIRO)
NEUE vs SIRO Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, SIRO has a market cap of 22B. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while SIRO trades at $109.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas SIRO's P/E ratio is 31.88. In terms of profitability, NEUE's ROE is +0.05%, compared to SIRO's ROE of +0.14%. Regarding short-term risk, NEUE is less volatile compared to SIRO. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check SIRO's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
NEUE vs HIMS Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, HIMS has a market cap of 7B. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while HIMS trades at $31.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas HIMS's P/E ratio is -315.90. In terms of profitability, NEUE's ROE is +0.05%, compared to HIMS's ROE of -0.02%. Regarding short-term risk, NEUE is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check HIMS's competition here
MiniMed Group, Inc. Common Stock (NASDAQ: MMED)
NEUE vs MMED Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, MMED has a market cap of 5.5B. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while MMED trades at $19.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas MMED's P/E ratio is -25.29. In terms of profitability, NEUE's ROE is +0.05%, compared to MMED's ROE of -0.14%. Regarding short-term risk, NEUE is less volatile compared to MMED. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check MMED's competition here
Omnicell, Inc. (NASDAQ: OMCL)
NEUE vs OMCL Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, OMCL has a market cap of 1.7B. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while OMCL trades at $36.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas OMCL's P/E ratio is 19.27. In terms of profitability, NEUE's ROE is +0.05%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, NEUE is less volatile compared to OMCL. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check OMCL's competition here
Alpha Tau Medical Ltd (NASDAQ: DRTS)
NEUE vs DRTS Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, DRTS has a market cap of 1.2B. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while DRTS trades at $13.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas DRTS's P/E ratio is -19.61. In terms of profitability, NEUE's ROE is +0.05%, compared to DRTS's ROE of -0.73%. Regarding short-term risk, NEUE is less volatile compared to DRTS. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check DRTS's competition here
Mesa Laboratories, Inc. (NASDAQ: MLAB)
NEUE vs MLAB Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, MLAB has a market cap of 574.4M. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while MLAB trades at $102.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas MLAB's P/E ratio is 10.36. In terms of profitability, NEUE's ROE is +0.05%, compared to MLAB's ROE of +0.04%. Regarding short-term risk, NEUE is less volatile compared to MLAB. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check MLAB's competition here
Standard BioTools Inc. (NASDAQ: LAB)
NEUE vs LAB Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, LAB has a market cap of 313.2M. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while LAB trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas LAB's P/E ratio is -11.43. In terms of profitability, NEUE's ROE is +0.05%, compared to LAB's ROE of -0.18%. Regarding short-term risk, NEUE is less volatile compared to LAB. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check LAB's competition here
Stereotaxis, Inc. (AMEX: STXS)
NEUE vs STXS Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, STXS has a market cap of 139M. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while STXS trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas STXS's P/E ratio is -8.35. In terms of profitability, NEUE's ROE is +0.05%, compared to STXS's ROE of -1.53%. Regarding short-term risk, NEUE is less volatile compared to STXS. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check STXS's competition here
Fonar Corp. (NASDAQ: FONR)
NEUE vs FONR Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, FONR has a market cap of 117.8M. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while FONR trades at $19.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas FONR's P/E ratio is 19.09. In terms of profitability, NEUE's ROE is +0.05%, compared to FONR's ROE of +0.04%. Regarding short-term risk, NEUE is more volatile compared to FONR. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check FONR's competition here
LENSAR Inc (NASDAQ: LNSR)
NEUE vs LNSR Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, LNSR has a market cap of 74.2M. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while LNSR trades at $6.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas LNSR's P/E ratio is 6.16. In terms of profitability, NEUE's ROE is +0.05%, compared to LNSR's ROE of -5.15%. Regarding short-term risk, NEUE is less volatile compared to LNSR. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check LNSR's competition here
Kindly MD, Inc. (NASDAQ: KDLY)
NEUE vs KDLY Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, KDLY has a market cap of 68.1M. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while KDLY trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas KDLY's P/E ratio is -15.48. In terms of profitability, NEUE's ROE is +0.05%, compared to KDLY's ROE of -0.85%. Regarding short-term risk, NEUE is less volatile compared to KDLY. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check KDLY's competition here
SANUWAVE Health Inc. (NASDAQ: SNWV)
NEUE vs SNWV Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, SNWV has a market cap of 50.6M. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while SNWV trades at $5.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas SNWV's P/E ratio is 17.82. In terms of profitability, NEUE's ROE is +0.05%, compared to SNWV's ROE of +17.28%. Regarding short-term risk, NEUE is less volatile compared to SNWV. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check SNWV's competition here
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO)
NEUE vs EKSO Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, EKSO has a market cap of 38.6M. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while EKSO trades at $15.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas EKSO's P/E ratio is -3.11. In terms of profitability, NEUE's ROE is +0.05%, compared to EKSO's ROE of -1.77%. Regarding short-term risk, NEUE is less volatile compared to EKSO. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check EKSO's competition here
HeartBeam, Inc. (NASDAQ: BEAT)
NEUE vs BEAT Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, BEAT has a market cap of 29.1M. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while BEAT trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas BEAT's P/E ratio is -0.94. In terms of profitability, NEUE's ROE is +0.05%, compared to BEAT's ROE of -10.34%. Regarding short-term risk, NEUE is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check BEAT's competition here
Sharps Technology Inc. Wt (NASDAQ: STSSW)
NEUE vs STSSW Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, STSSW has a market cap of 839.4K. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while STSSW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas STSSW's P/E ratio is -0.03. In terms of profitability, NEUE's ROE is +0.05%, compared to STSSW's ROE of N/A. Regarding short-term risk, NEUE is more volatile compared to STSSW. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check STSSW's competition here
Span-America Medical Systems, Inc. (NASDAQ: SPAN)
NEUE vs SPAN Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, SPAN has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while SPAN trades at $29.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas SPAN's P/E ratio is N/A. In terms of profitability, NEUE's ROE is +0.05%, compared to SPAN's ROE of +0.17%. Regarding short-term risk, NEUE is less volatile compared to SPAN. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check SPAN's competition here
Exactech, Inc. (NASDAQ: EXAC)
NEUE vs EXAC Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, EXAC has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while EXAC trades at $49.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas EXAC's P/E ratio is 3510.33. In terms of profitability, NEUE's ROE is +0.05%, compared to EXAC's ROE of +0.00%. Regarding short-term risk, NEUE is more volatile compared to EXAC. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check EXAC's competition here
Advisory Board Co. (The) (NASDAQ: ABCO)
NEUE vs ABCO Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, ABCO has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while ABCO trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas ABCO's P/E ratio is 0.52. In terms of profitability, NEUE's ROE is +0.05%, compared to ABCO's ROE of +0.19%. Regarding short-term risk, NEUE is more volatile compared to ABCO. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check ABCO's competition here
Surgical Care Affiliates, Inc. (NASDAQ: SCAI)
NEUE vs SCAI Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, SCAI has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while SCAI trades at $55.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas SCAI's P/E ratio is 63.45. In terms of profitability, NEUE's ROE is +0.05%, compared to SCAI's ROE of +0.09%. Regarding short-term risk, NEUE is more volatile compared to SCAI. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check SCAI's competition here
Landauer Inc. (NYSE: LDR)
NEUE vs LDR Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, LDR has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while LDR trades at $67.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas LDR's P/E ratio is N/A. In terms of profitability, NEUE's ROE is +0.05%, compared to LDR's ROE of +1.17%. Regarding short-term risk, NEUE is more volatile compared to LDR. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check LDR's competition here
Mazor Robotics Ltd. (NASDAQ: MZOR)
NEUE vs MZOR Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, MZOR has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while MZOR trades at $58.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas MZOR's P/E ratio is -70.18. In terms of profitability, NEUE's ROE is +0.05%, compared to MZOR's ROE of -0.14%. Regarding short-term risk, NEUE is more volatile compared to MZOR. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check MZOR's competition here
Med-Design Corp. (The) (NASDAQ: MEDC)
NEUE vs MEDC Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, MEDC has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while MEDC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas MEDC's P/E ratio is N/A. In terms of profitability, NEUE's ROE is +0.05%, compared to MEDC's ROE of N/A. Regarding short-term risk, NEUE is less volatile compared to MEDC. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check MEDC's competition here
St. Jude Medical, Inc. (NYSE: STJ)
NEUE vs STJ Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, STJ has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while STJ trades at $80.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas STJ's P/E ratio is 34.69. In terms of profitability, NEUE's ROE is +0.05%, compared to STJ's ROE of +0.21%. Regarding short-term risk, NEUE is more volatile compared to STJ. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check STJ's competition here
LifePoint Health, Inc. (NASDAQ: LPNT)
NEUE vs LPNT Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, LPNT has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while LPNT trades at $64.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas LPNT's P/E ratio is 67.44. In terms of profitability, NEUE's ROE is +0.05%, compared to LPNT's ROE of +0.05%. Regarding short-term risk, NEUE is more volatile compared to LPNT. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check LPNT's competition here
Cynosure, Inc. (NASDAQ: CYNO)
NEUE vs CYNO Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, CYNO has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while CYNO trades at $66.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas CYNO's P/E ratio is 105.35. In terms of profitability, NEUE's ROE is +0.05%, compared to CYNO's ROE of +0.03%. Regarding short-term risk, NEUE is more volatile compared to CYNO. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check CYNO's competition here
Pharmerica Corporation (NYSE: PMC)
NEUE vs PMC Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, PMC has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while PMC trades at $29.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas PMC's P/E ratio is 47.95. In terms of profitability, NEUE's ROE is +0.05%, compared to PMC's ROE of +0.04%. Regarding short-term risk, NEUE is more volatile compared to PMC. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check PMC's competition here
Abaxis, Inc. (NASDAQ: ABAX)
NEUE vs ABAX Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, ABAX has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while ABAX trades at $83.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas ABAX's P/E ratio is 70.62. In terms of profitability, NEUE's ROE is +0.05%, compared to ABAX's ROE of +0.10%. Regarding short-term risk, NEUE is more volatile compared to ABAX. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check ABAX's competition here
Envision Healthcare Corporation (NYSE: EVHC)
NEUE vs EVHC Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, EVHC has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while EVHC trades at $45.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas EVHC's P/E ratio is -3.20. In terms of profitability, NEUE's ROE is +0.05%, compared to EVHC's ROE of +0.07%. Regarding short-term risk, NEUE is more volatile compared to EVHC. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check EVHC's competition here
Cotiviti Holdings, Inc. (NYSE: COTV)
NEUE vs COTV Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, COTV has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while COTV trades at $44.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas COTV's P/E ratio is 26.51. In terms of profitability, NEUE's ROE is +0.05%, compared to COTV's ROE of +0.14%. Regarding short-term risk, NEUE is more volatile compared to COTV. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check COTV's competition here
AmSurg Corp (NASDAQ: AMSG)
NEUE vs AMSG Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, AMSG has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while AMSG trades at $67.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas AMSG's P/E ratio is N/A. In terms of profitability, NEUE's ROE is +0.05%, compared to AMSG's ROE of +0.08%. Regarding short-term risk, NEUE is less volatile compared to AMSG. This indicates lower risk in terms of short-term price fluctuations for NEUE.Check AMSG's competition here
Spectranetics Corp. (The) (NASDAQ: SPNC)
NEUE vs SPNC Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, SPNC has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while SPNC trades at $38.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas SPNC's P/E ratio is -24.03. In terms of profitability, NEUE's ROE is +0.05%, compared to SPNC's ROE of -0.61%. Regarding short-term risk, NEUE is more volatile compared to SPNC. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check SPNC's competition here
Derma Sciences, Inc. (NASDAQ: DSCI)
NEUE vs DSCI Comparison August 2026
NeueHealth, Inc. (NYSE: NEUE) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NEUE stands at 60.9M. In comparison, DSCI has a market cap of 0. Regarding current trading prices, NEUE is priced at $6.75 on the NYSE, while DSCI trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NEUE currently has a P/E ratio of -0.38, whereas DSCI's P/E ratio is -0.02. In terms of profitability, NEUE's ROE is +0.05%, compared to DSCI's ROE of -0.00%. Regarding short-term risk, NEUE is more volatile compared to DSCI. This indicates higher risk in terms of short-term price fluctuations for NEUE.Check DSCI's competition here